How should DSM-V criteria for schizophrenia include cognitive impairment?

Neurocognitive impairment is considered a core component of schizophrenia and is increasingly under investigation as a potential treatment target. On average, cognitive impairment is severe to moderately severe compared with healthy controls, and almost all patients with schizophrenia demonstrate cognitive decrements compared with their expected level if they had not developed the illness. Compared with patients with affective disorders, cognitive impairment in schizophrenia appears earlier, is more severe, and tends to be more independent of clinical symptoms. While the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, description of schizophrenia includes several references to cognitive impairment, neither the diagnostic criteria nor the subtypology of schizophrenia include a requirement of cognitive impairment. We forward for consideration a proposal that the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria include a specific criterion of "a level of cognitive functioning suggesting a consistent severe impairment and/or a significant decline from premorbid levels considering the patient's educational, familial, and socioeconomic background." The inclusion of this criterion may increase the "point of rarity" with affective psychoses and may increase clinicians' awareness of cognitive impairment, potentially leading to more accurate prognosis and better treatment outcomes. Future research will need to address the validity of these possibilities. The reliable determination of cognitive impairment as part of a standard diagnostic evaluation may present challenges to diagnosticians with limited resources or insufficient expertise. Various cognitive assessment methods for clinicians, including brief assessments and interview-based assessments, are discussed. Given the current emphasis on the development of cognitive treatments, the evaluation of cognition in schizophrenia is an essential component of mental health education.

[1]  Diana O. Perkins,et al.  A longitudinal study of neurocognitive function in individuals at-risk for psychosis , 2006, Schizophrenia Research.

[2]  Michael F. Green,et al.  Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial , 2006, Neuropsychopharmacology.

[3]  Robert K. Heaton,et al.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. , 2006, The American journal of psychiatry.

[4]  Philip D. Harvey,et al.  The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. , 2006, The American journal of psychiatry.

[5]  Jim van Os,et al.  Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review , 2005, Schizophrenia Research.

[6]  Philip D. Harvey,et al.  Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. , 2005, Archives of general psychiatry.

[7]  Margaret P. Poe,et al.  Defining a cognitive function decrement in schizophrenia , 2005, Biological Psychiatry.

[8]  Michael F. Green,et al.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. , 2005, Schizophrenia bulletin.

[9]  C. Pantelis,et al.  Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. , 2005, The American journal of psychiatry.

[10]  J. Gold.  Cognitive deficits as treatment targets in schizophrenia , 2004, Schizophrenia Research.

[11]  Michael F. Green,et al.  Identification of separable cognitive factors in schizophrenia , 2004, Schizophrenia Research.

[12]  F. Dickerson,et al.  Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status , 2004, Schizophrenia Research.

[13]  D. Naber,et al.  Memory and attention performance in psychiatric patients: Lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results , 2004, Journal of the International Neuropsychological Society.

[14]  C. Pantelis,et al.  Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. , 2003, The American journal of psychiatry.

[15]  E. Stip,et al.  Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. , 2003, Comprehensive psychiatry.

[16]  M. Bell,et al.  INITIAL AND FINAL WORK PERFORMANCE IN SCHIZOPHRENIA:: COGNITIVE AND SYMPTOM PREDICTORS , 2003, The Journal of nervous and mental disease.

[17]  Veena Kumari,et al.  Longitudinal study of symptoms and cognitive function in chronic schizophrenia , 2003, Schizophrenia Research.

[18]  S. Hyman,et al.  What Are the Right Targets for Psychopharmacology? , 2003, Science.

[19]  S. Hyman,et al.  Medicine. What are the right targets for psychopharmacology? , 2003, Science.

[20]  R. Kendell,et al.  Distinguishing between the validity and utility of psychiatric diagnoses. , 2003, The American journal of psychiatry.

[21]  Beng-Choon Ho,et al.  Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. , 2002, The American journal of psychiatry.

[22]  James G. Scott,et al.  Sensitivity of the Semantic Fluency Subtest of the Repeatable Battery for the Assessment of Neuropsychological Status , 2002, Psychological reports.

[23]  Richie Poulton,et al.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.

[24]  Philip D. Harvey,et al.  The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. , 2001, Comprehensive psychiatry.

[25]  R. Spitzer.  Values and Assumptions in the Development of DSM-III and DSM-III-R: An Insider's Perspective and a Belated Response to Sadler, Hulgus, and Agich's "On Values in Recent American Psychiatric Classification" , 2001, The Journal of nervous and mental disease.

[26]  Jean Addington,et al.  Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study , 2000, Schizophrenia Research.

[27]  J. Lieberman,et al.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.

[28]  D. Braff,et al.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.

[29]  A Reichenberg,et al.  Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. , 1999, The American journal of psychiatry.

[30]  J. Addington,et al.  Neurocognitive and social functioning in schizophrenia. , 1999, Schizophrenia bulletin.

[31]  Philip D. Harvey,et al.  Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. , 1998, The American journal of psychiatry.

[32]  L. Leach,et al.  On the nature and pattern of neurocognitive function in major depressive disorder. , 1998, Neuropsychiatry, neuropsychology, and behavioral neurology.

[33]  R. J. van den Bosch,et al.  Causal mechanisms of subjective cognitive dysfunction in schizophrenic and depressed patients. , 1998, The Journal of nervous and mental disease.

[34]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[35]  L. Altshuler,et al.  Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. , 1998, Archives of general psychiatry.

[36]  Jane S. Paulsen,et al.  Is it possible to be schizophrenic yet neuropsychologically normal? , 1997, Neuropsychology.

[37]  M. Albus,et al.  Contrasts in neuropsychological test profile between patients with first‐eoisode schizophienia and first‐episohe affective disorders , 1996, Acta psychiatrica Scandinavica.

[38]  M. Davidson,et al.  Cognitive impairment as a target for pharmacological treatment in schizophrenia , 1995, Schizophrenia Research.

[39]  G. Agich,et al.  On values in recent American psychiatric classification. , 1994, The Journal of medicine and philosophy.

[40]  R. Gur,et al.  Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.

[41]  R. Heinrichs,et al.  Neurocognitive subtypes of chronic schizophrenia , 1993, Schizophrenia Research.

[42]  G. Bryson,et al.  Differential rate of neuropsychological dysfunction in psychiatric disorders: comparison between the Halstead-Reitan and Luria-Nebraska batteries. , 1993, Perceptual and motor skills.

[43]  M. Strauss,et al.  Relations of symptoms to cognitive deficits in schizophrenia. , 1993, Schizophrenia bulletin.

[44]  Philip D. Harvey,et al.  Cognitive deficits and thought disorder: II. An 8-month followup study. , 1990, Schizophrenia bulletin.